期刊文献+

药品价格管理的相关因素分析

下载PDF
导出
出处 《上海医药》 CAS 2006年第5期212-214,共3页 Shanghai Medical & Pharmaceutical Journal
  • 相关文献

参考文献4

二级参考文献18

  • 1陈英耀.OECD国家卫生费用和卫生服务的趋势[J].中国卫生资源,2001,4(3):141-144. 被引量:10
  • 2Drummond,MF.The role of economic evaluation in the pricing and reimbursement of medicines[J] .Health Policy, 1997,40:199. 被引量:1
  • 3Ministry of health, welfare and sports. The Future of Health Insurance System [ S ]. Dutch, 1999. 被引量:1
  • 4Ziekenfondsraad.Dutch Guidelines for Pharmacoeconomic Research [ S]. Ziekenfondsraad amst elveen, March,1999. 被引量:1
  • 5Tobin H,Tumer N,Wyatt G.Pharmacoeconomics 2002:A Concise Guide [ S ]. PPR Communications, Ltd., Cambridge, UK. 2002. 被引量:1
  • 6Torrance G.Current experience with guidelines for economic evaluation in Canada[J ]. Drug Information Journal, 1996,30: 507. 被引量:1
  • 7Glennie JL,Torrance GW,Baladi JF,et al .The revised Canadian guidelines for the economic evaluation of pharmaceuticals [ J ] . Pharmacoeconom ics, 1999,15(5): 459. 被引量:1
  • 8Anis AH,Gagnon Y.Using economic evaluations to make formulary coverage decisions: so much for guidelines[J]. Pharmacoeconomics, 2000,18(1): 55. 被引量:1
  • 9Kanavos P.Pharmaceutical Pricing and Reimbursement in Europe- 2002[ S ].PJB Publications Ltd. 2002. 被引量:1
  • 10National Institute for Clinical Excellence. Technical Guidance for Manufacturers and Sponsors on Making a Submission to a Technology Appraisal [S] .March,2001 被引量:1

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部